| Brigette King, | |
|
3535 Southern Blvd, Kettering, OH 45429 | |
| (937) 298-4331 | |
| Not Available |
| Full Name | Brigette King |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 3535 Southern Blvd, Kettering, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376903930 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | RN415671 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Brigette King, 2956 Purdue Rd, Kettering, OH 45420 Ph: (937) 608-1310 | Brigette King, 3535 Southern Blvd, Kettering, OH 45429 Ph: (937) 298-4331 |
News Archive
Two Columbia Data Science Institute graduates work for the startup Surgical Safety Technologies (SST), whose data-driven technology is helping hospitals become more efficient, streamlined and safer.
A remarkable recent increase in the diagnosis of vocal-cord cancer in young adults appears to be the result of infection with strains of human papilloma virus that also cause cervical cancer and other malignancies.
Recipes can be handed down from generation to generation and so can myths surrounding food safety - sometimes with sickening consequences. September is National Food Safety Education Month and the Partnership for Food Safety Education (PFSE), in cooperation with the Food and Drug Administration, the Centers for Disease Control and Prevention, and the U.S. Department of Agriculture, is marking the occasion with an outreach to consumers aimed at debunking four common food safety myths.
GTC Biotherapeutics, Inc. ("GTC", NASDAQ: GTCB) announced that it has entered into an agreement with its strategic partner, LFB Biotechnologies (Les Ulis, France), pursuant to which LFB has agreed to provide $7 million of new loan financing to GTC.
Warner Chilcott plc today announced that it has agreed to terminate its existing co-promotion agreement with Novartis and signed a definitive agreement to purchase the U.S. rights to Enablex® from Novartis for $400 million in cash. Enablex (darifenacin) is a product indicated to treat adults with symptoms of overactive bladder, which had U.S. sales of approximately $190 million for the year ended December 31, 2009.
› Verified 8 days ago
Susan Kay Zann, RNFS Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3535 Southern Blvd, Kettering, OH 45429 Phone: 937-395-8608 | |
Joan S Koble, CRNFA Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3535 Southern Blvd, Kettering, OH 45429 Phone: 937-298-4331 | |
Mrs. Erica R Gwin, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3148 Larue Dr, Kettering, OH 45429 Phone: 937-789-0579 | |
Tiffany Thompson, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1256 Robert Dickey Pkwy, Kettering, OH 45409 Phone: 937-694-6156 | |
Leigh Obie, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 5462 Montgomery Square Dr, Kettering, OH 45440 Phone: 937-329-1051 | |
Robyn Avery Michael, REGISTERED NURSE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2632 Woodman Center Ct, Kettering, OH 45420 Phone: 937-739-7100 Fax: 480-687-7361 | |
Mrs. Deborah Ann Wise, CNS Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 3700 Southern Blvd Ste 401, Kettering, OH 45429 Phone: 855-500-2873 Fax: 937-281-3913 |